Home›Enalapril Maleate And Hydrochlorothiazide›Enalapril Maleate And Hydrochlorothiazide + Lithium

Does Enalapril Maleate And Hydrochlorothiazide Interact with Lithium?

CDI records a major classification for Enalapril Maleate And Hydrochlorothiazide and Lithium. The stored summary is: Lithium toxicity has been reported in patients receiving enalapril concomitantly with lithium; effects are reversible upon discontinuation. The mechanism involves ace inhibitors cause elimination of sodium, reducing lithium clearance. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.

Severity
Major
Enalapril Maleate And Hydrochlorothiazide Class
Thiazide Diuretic
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

Recorded Mechanism

ACE inhibitors cause elimination of sodium, reducing lithium clearance

What To Tell Your Doctor or Pharmacist

If you are taking Enalapril Maleate And Hydrochlorothiazide and your doctor is considering prescribing Lithium (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Enalapril Maleate And Hydrochlorothiazide(Vaseretic)+💊 Lithium(Lithium)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Thiazide Diuretic
Drug B class
—
Source
NLP:enalapril maleate and hydrochlorothiazide

What this means in plain English

Lithium toxicity has been reported in patients receiving enalapril concomitantly with lithium; effects are reversible upon discontinuation.

About Enalapril Maleate And Hydrochlorothiazide and Lithium

Enalapril Maleate And Hydrochlorothiazide is a Thiazide Diuretic. Enalapril Maleate And Hydrochlorothiazide is also sold under the brand name Vaseretic. Both Enalapril Maleate And Hydrochlorothiazide and Lithium carry an FDA boxed warning — the agency's most serious safety designation.

Source and Limitations

This record was produced by automated extraction from drug-label information, including AI processing. The summary and mechanism are not verbatim FDA quotations. The drug profiles below may describe different formulations from the source label. Confirm the exact product and route with your pharmacist. This page does not establish independent clinical review.

📖 Source: NLP:enalapril maleate and hydrochlorothiazide

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Enalapril Maleate And Hydrochlorothiazide and Lithium against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
How this information is prepared: CDI uses automated extraction, including AI, to summarize drug labeling from openFDA and includes separately identified curated-reference records. RxNorm helps identify medications; it does not verify interaction claims. Extracted summaries and CDI severity classifications can contain errors and are not verbatim FDA statements or independent clinical review. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.

CDI: source-linked explanations